Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015
DateTitle 
03/04/19BioTelemetry, Inc. Completes Acquisition of Geneva Healthcare, Inc.
MALVERN, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the Company has completed its acquisition of Geneva Healthcare, Inc., the leading provider of remote monitoring for implantable cardiac devices. Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented: “We are exci... 
Printer Friendly Version
02/28/19BioTelemetry, Inc. Elects Laura Dietch and Tiffany Olson to its Board of Directors
MALVERN, Pa., Feb. 28, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the election of Laura Dietch and Tiffany Olson to BioTelemetry’s Board of Directors. Ms. Dietch has more than twenty-five years of experience in the medical device industry as a Chief Executive Officer, company co-founder, director, fundraiser, inventor... 
Printer Friendly Version
02/21/19BioTelemetry, Inc. Reports Fourth Quarter 2018 Financial Results
Delivered Best Performance in Company’s History Exceeded Expectations  MALVERN, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the fourth quarter ended December 31, 2018. Quarter Highlights Recognized quarterly revenue of $103.6 million Reached 12.9% year-over-year revenue growth Achie... 
Printer Friendly Version
02/11/19BioTelemetry, Inc. to Release Fourth Quarter 2018 Earnings Results on February 21, 2019
MALVERN, Pa., Feb. 11, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2018 earnings on Thursday, February 21 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Thursday, February 21, 2019.  The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.  If you are unable to participate during the live webcast, an archive will be available on ... 
Printer Friendly Version
01/28/19BioTelemetry, Inc. to Acquire Geneva Healthcare, Inc.
Creates Most Comprehensive Connected Health Solution in Cardiology Market MALVERN, Pa., Jan. 28, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and Geneva Healthcare, Inc. (“Geneva”), the leading provider of remote monitoring for implantable cardiac devices are pleased to announce that the companies have entered into a definit... 
Printer Friendly Version


STOCK QUOTE
BEAT (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$68.78
Change (%) Stock is Up 0.56 (0.82%)
Volume379,545
Data as of 03/19/19
4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

EMAIL ALERTS
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds
Copyright © BioTelemetry, Inc. 2013, All Rights Reserved